CASE REPORTInlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction
REFERENCES (12)
- et al.
Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians
Chest.
(1998) - et al.
Helicobacter pylori and heterotopic gastric mucosa in the upper esophagus (the inlet patch)
Am J Gastroenterol.
(2003) - et al.
Acid secretion from an esophageal inlet patch demonstrated by ambulatory pH monitoring
Gastroenterology.
(1998) - et al.
The diagnosis and treatment of cough
N Engl J Med.
(2000) - et al.
Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy
Am Rev Respir Dis.
(1990) - et al.
Impact of chronic cough on quality of life
Arch Intern Med.
(1998)
Cited by (22)
Radiofrequency ablation of symptomatic cervical inlet patch using a through-the-scope device: a pilot study
2016, Gastrointestinal EndoscopyEsophageal Inlet Patch: An Under-Recognized Cause of Symptoms in Children
2016, Journal of PediatricsCitation Excerpt :No endoscopic or histological changes were evident in any of these patients. Traditionally considered a nonpathological incidental finding, IP has now been identified as the possible cause of unexplained digestive and respiratory symptoms, such as chronic cough, laryngospasm, sore throat, globus pharyngeus, dysphagia, hoarseness, and vocal cord dysfunction,2-7,9-12 at least in in a subgroup of patients. Moreover, case reports have shown that IP can play a role in the development of severe complications, such as webs, strictures, ulcers, perforation, fistulas, and adenocarcinoma.14-32
Endoscopic diagnosis and treatment of inlet patch: Justification, techniques, and results
2014, Techniques in Gastrointestinal EndoscopyCitation Excerpt :In case of histopathologically detected parietal cells in the EGIP of a symptomatic patient, medical acid suppressive therapy with proton pump inhibitors (PPI) should improve symptoms. This therapeutic success has already been described in various case reports [25-27] but has never been proven in a prospective, controlled trial. Therefore, it remains unclear whether the PPI therapy should be the treatment of choice because in our experience PPI response was rather poor in patients presenting with oropharyngeal symptoms with a coexisting EGIP [16,28].
Prevalence of esophageal inlet patch and clinical characteristics of the patients
2019, Revista de Gastroenterologia de MexicoA multidisciplinary approach to identifying and managing heterotopic gastric inlet patches
2024, Neurogastroenterology and Motility